II
LUMO

Inspire Investing’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Inspire Investing’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25
Closed – – 748
2020
Q1 		$0 Buy
+25
New +$349 ﹤0.01% 805
2018
Q1 		– Sell
-12
Closed -$1K – 740
2017
Q4 		$1K Buy
+12
New +$993 ﹤0.01% 899

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Inspire Investing's LUMO Position: Q2 2020 in Review

Inspire Investing sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2020, closing a stake of 25 shares.

Inspire Investing first reported a position in LUMO in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 43 funds tracked by Wall St. Rank hold LUMO as of Q2 2020.

  • Inspire Investing reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Inspire Investing sold 25 Lumos Pharma, Inc. Common Stock shares in Q2 2020.
  • Inspire Investing first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • Inspire Investing's Lumos Pharma, Inc. Common Stock position peaked at $1K in Q4 2017.
  • 43 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2020.

Based on Inspire Investing's 13F filing for Q2 2020, filed 12 Aug 2020.